FDA Drugs (New Approvals & NDA)Original article
Considerations for Potential Future Therapeutic Use of Psychedelic Drugs Public Hearing - 09/14/2026
Neutral
AI Analysis
Summary
The FDA is announcing a public hearing on September 14, 2026 to discuss the potential future therapeutic use of psychedelic drugs. This is a routine regulatory announcement with no specific drug approvals, clinical data, or company involvement disclosed.
Importance:2/10
Sentiment:
0.00
psychedelic_drugsFDA_hearingregulatorytherapeutic_use
Read the original article
Published by FDA Drugs (New Approvals & NDA) on August 24, 2026 6:33 PM